<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_ajCdZ3j">Cost-effectiveness and challenges of implementing intensive blood pressure goals and team-based care</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2019-11-22">2019 November 22.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>PharmD</roleName><forename type="first">Catherine</forename><forename type="middle">G</forename><surname>Derington</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> . Department of Pharmacy , Kaiser Permanente Colorado , Aurora , CO</note>
								<orgName type="department">Department of Pharmacy</orgName>
								<orgName type="institution">Kaiser Permanente Colorado</orgName>
								<address>
									<settlement>Aurora</settlement>
									<region>CO</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> . Department of Clinical Pharmacy , University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences , Aurora , CO</note>
								<orgName type="department" key="dep1">Department of Clinical Pharmacy</orgName>
								<orgName type="department" key="dep2">School of Pharmacy and Pharmaceutical Sciences</orgName>
								<orgName type="institution">University of Colorado Skaggs</orgName>
								<address>
									<settlement>Aurora</settlement>
									<region>CO</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PharmD</roleName><forename type="first">Jordan</forename><forename type="middle">B</forename><surname>King</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> . Department of Population Health Sciences , University of Utah , School of Medicine , Salt Lake City , UT</note>
								<orgName type="department" key="dep1">Department of Population Health Sciences</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">University of Utah</orgName>
								<address>
									<settlement>Salt Lake City</settlement>
									<region>UT</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MPH</roleName><forename type="first">Kelsey</forename><forename type="middle">B</forename><surname>Bryant</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> . Department of Medicine , Columbia University Medical Center , New York , NY</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Columbia University Medical Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD, MPH, RN</roleName><forename type="first">Blake</forename><forename type="middle">T</forename><surname>Mcgee</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> . Byrdine F. Lewis College of Nursing &amp; Health Professions , Georgia State University , Atlanta , GA</note>
								<orgName type="department">Byrdine F. Lewis College of Nursing &amp; Health Professions</orgName>
								<orgName type="institution">Georgia State University</orgName>
								<address>
									<settlement>Atlanta</settlement>
									<region>GA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MPH</roleName><forename type="first">Andrew</forename><forename type="middle">E</forename><surname>Moran</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> . Department of Medicine , Columbia University Medical Center , New York , NY</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Columbia University Medical Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">William</forename><forename type="middle">S</forename><surname>Weintraub</surname></persName>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>6</label> . MedStar Washington Hospital Center , Washington , DC MS ; 295 Chipeta Way , Salt Lake City , UT 84112 , Office: 801. 213.1331</note>
								<orgName type="department">MS</orgName>
								<orgName type="institution">MedStar Washington Hospital Center</orgName>
								<address>
									<addrLine>295 Chipeta Way Office: 801.</addrLine>
									<postCode>84112 213.1331</postCode>
									<settlement>Washington Salt Lake City</settlement>
									<region>DC UT</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PharmD</roleName><forename type="first">Brandon</forename><forename type="middle">K</forename><surname>Bellows</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> . Department of Medicine , Columbia University Medical Center , New York , NY</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Columbia University Medical Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>PharmD</roleName><forename type="first">Adam</forename><forename type="middle">P</forename><surname>Bress</surname></persName>
							<email>adam.bress@hsc.utah.edu</email>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> . Department of Population Health Sciences , University of Utah , School of Medicine , Salt Lake City , UT</note>
								<orgName type="department" key="dep1">Department of Population Health Sciences</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">University of Utah</orgName>
								<address>
									<settlement>Salt Lake City</settlement>
									<region>UT</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_YUEDf4P">Cost-effectiveness and challenges of implementing intensive blood pressure goals and team-based care</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2019-11-22">2019 November 22.</date>
						</imprint>
					</monogr>
					<idno type="MD5">344AF65FCC735733ABA7E7C391901415</idno>
					<idno type="DOI">10.1007/s11906-019-0996-x</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T10:26+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_5swSQxv">cost effectiveness</term>
					<term xml:id="_TAeXJYE">patient care team</term>
					<term xml:id="_xugeKfF">hypertension</term>
					<term xml:id="_cmkaxv9">blood pressure</term>
					<term xml:id="_RVmkNYD">pharmacists</term>
					<term xml:id="_gRVsX5v">nurses Systolic Blood Pressure</term>
					<term xml:id="_nNtxX5h">SPRINT: Systolic Blood Pressure Intervention Trial</term>
					<term xml:id="_DEKaaSh">USD: United States</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_6dyEBQy"><p xml:id="_E498HPu"><s xml:id="_STWjyZ4">Purpose: Review the effectiveness, cost-effectiveness, and implementation challenges of intensive blood pressure (BP) control and team-based care initiatives.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_hARGesy">Recent Findings:</head><p xml:id="_qmvDEFB"><s xml:id="_Ax6BpTq">Intensive BP control is an effective and cost-effective intervention, yet implementation in routine clinical practice is challenging.</s><s xml:id="_VrN6Rmq">Several models of team-based care for hypertension management have been shown to be more effective than usual care to control BP.</s><s xml:id="_N5fBFZB">Additional research is needed to determine the cost-effectiveness of team-based care models relative to one another and as they relate to implementing intensive BP goals.</s></p><p xml:id="_fnfbeH7"><s xml:id="_TKg6ZaA">Summary: As a focus of healthcare shifts to value (i.e., cost, effectiveness, and patient preferences), formal cost-effectiveness analyses will inform which team-based initiatives hold the highest value in different healthcare settings with different populations and needs.</s><s xml:id="_kzXx44v">Several challenges, including clinical inertia, financial investment, and billing restrictions for pharmacistdelivered services, will need to be addressed in order to improve public health through intensive BP control and team-based care.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6XcV9v8">Introduction</head><p xml:id="_jsZy826"><s xml:id="_7a3EwYS">Globally, high blood pressure (BP) is the leading modifiable risk factor for cardiovascular morbidity and mortality <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref>.</s><s xml:id="_cShnb2q">Of the 116 million American adults with hypertension, 53.4% are treated, and 24.7% are both treated and have controlled BP <ref type="bibr" target="#b3">[4]</ref>.</s><s xml:id="_DaQbqWQ">Given the widespread availability of low-cost, effective antihypertensive medications, uncontrolled BP represents a missed public health opportunity for the prevention of cardiovascular, neurologic, and renal diseases.</s></p><p xml:id="_exYdQjv"><s xml:id="_wv33Xph">The 2017 American College of Cardiology/American Heart Association (ACC/AHA) BP guidelines lowered the threshold for defining hypertension and recommended a more intensive BP threshold for initiation and intensification of antihypertensive medication.</s><s xml:id="_FePAMeQ">Implementing and maintaining these more intensive BP goals requires significant culture shifts and investments by health systems.</s><s xml:id="_ECJkmmr">To achieve and maintain lower BP treatment goals, the ACC/AHA guidelines endorse comprehensive, team-based care (TBC) for hypertension management <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_jqhbJ57">Furthermore, the Centers for Disease Control and Prevention recently incorporated TBC into its strategic initiatives to improve BP control <ref type="bibr" target="#b7">[8]</ref>.</s></p><p xml:id="_4DcQYmX"><s xml:id="_X6Wz99E">Health systems are tasked with maximizing the value of healthcare services by improving quality and patient satisfaction while controlling costs <ref type="bibr" target="#b8">[9]</ref>.</s><s xml:id="_mfePbkG">In the context of hypertension management, clinicians and health systems must carefully consider the logistics of targeting intensive BP goals and, where needed, how to implement TBC programs to reach intensive BP goals.</s><s xml:id="_jVSRdeb">These health services must be effective and cost-effective while considering patient preferences and quality of life <ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref>.</s></p><p xml:id="_4whqTkn"><s xml:id="_9gDvWDB">The objective of this review is to appraise the current literature regarding the effectiveness and cost-effectiveness of intensive systolic BP (SBP) goals and implementation of TBC interventions.</s><s xml:id="_GVDjSuZ">We also discuss challenges of implementing these strategies within health systems in the US.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5sQtRWU">Cost-effectiveness analysis translates evidence from diverse sources to quantify the value of healthcare interventions</head><p xml:id="_NFJ34B6"><s xml:id="_SFjd5T4">Cost-effectiveness analysis (CEA) provides a framework for payers, population health managers, governments, and clinicians to quantify the incremental health benefits, costs, and downstream consequences of an intervention relative to other options.</s><s xml:id="_4dKwx9p">While CEA incurs criticisms regarding uncertainty about how both cost and health outcome inputs are estimated, these analyses reveal the underlying assumptions clinicians make when considering a new therapy compared to a previous standard (e.g., how much weight to place on risk vs. benefit when initiating a medication therapy for a particular patient demographic).</s><s xml:id="_RPhU2YP">As such, decision-makers in the US have historically been reluctant to use CEA formally to prioritize health services <ref type="bibr" target="#b13">[14]</ref>.</s><s xml:id="_8YTG9c9">However, the ACC and AHA recommend that CEAs be used in creating treatment guidelines and recently used them to make recommendations for lipid lowering treatments <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16]</ref>.</s><s xml:id="_kRNwmjW">The 2018 ACC/AHA Cholesterol Management Guidelines acknowledged that proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, a novel antihyperlipidemic class, are low value for most patients at conventional cost-effectiveness thresholds and recommended maximally tolerated statins and ezetimibe be used first in high-risk patients <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref>.</s></p><p xml:id="_UKKReez"><s xml:id="_U7dUAxn">High-quality evidence supports the cost and population health impacts of widespread achievement of standard BP goals (i.e., SBP/diastolic [DBP] &lt;140/90 mm Hg).</s><s xml:id="_EE3Z7ya">One analysis found that if 100% of guideline-recommended services were successfully implemented, the incremental cost per person newly-attaining BP treatment goals over two years would be $1,696 (2009 US Dollars [USD]) overall, $801 for moderate hypertension, and $850 for severe hypertension <ref type="bibr" target="#b18">[19]</ref>.</s><s xml:id="_Qk3rmgc">Additionally, treating to a standard SBP/DBP goal of &lt;140/90 mm Hg is cost-saving or cost-effective in most age and sex groups <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b20">21]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6AX947n">Targeting intensive BP goals reduces CVD risk compared to standard goals</head><p xml:id="_2AZwC4h"><s xml:id="_3rkAhca">Meta-analyses of randomized trials of BP-lowering show that targeting an intensive SBP goal (i.e., lower by at least 10 mm Hg or to less than 130 mm Hg) results in a larger relative risk reduction in all-cause mortality and cardiovascular disease (CVD) events, compared to targeting standard BP goals (e.g., &lt;140 mm Hg) <ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>.</s><s xml:id="_krnKyzq">In 2015, SPRINT (Systolic Blood Pressure Intervention Trial) demonstrated that treating to an intensive SBP target of &lt;120 mm Hg compared to a standard target of &lt;140 mm Hg significantly reduced all-cause mortality and CVD events among high CVD risk adults without a history of diabetes, stroke, or heart failure <ref type="bibr" target="#b24">[25]</ref>.</s><s xml:id="_4YtEy5W">With and without the SPRINT results, a meta-analysis of 42 BPlowering trials with 144,220 participants concluded that achieving an SBP of 120-124 mm Hg was associated with a significantly lower risk of CVD events compared to groups with higher achieved SBP <ref type="bibr" target="#b21">[22]</ref>.</s><s xml:id="_88jfxdn">These data prompted the 2017 ACC/AHA BP guidelines to recommend a SBP/DBP goal of &lt;130/80 mm Hg in treated adults less than 65 years old with prior CVD or a 10-year CVD risk greater than 10%, and an SBP goal of &lt;130 mm Hg for adults aged 65 years or older <ref type="bibr" target="#b4">[5]</ref>.</s><s xml:id="_hGMgbAC">Over ten years, achieving and maintaining the 2017 ACC/AHA BP goals compared with achieving 2003 Seventh Joint National Committee Report goals or achieving 2014 Eighth Joint National Committee goals is projected to prevent 0.5 million (95% confidence interval [CI], 0.2-0.7 million) or 1.4 million (95% CI, 0.6-2.0 million) CVD events, respectively <ref type="bibr" target="#b25">[26]</ref>.</s></p><p xml:id="_e8x9PTA"><s xml:id="_PUpeapA">Concerns remain that the benefits of targeting intensive SBP goals as described in SPRINT and meta-analyses do not apply to all patient populations, particularly those with diabetes.</s><s xml:id="_5TpF65q">The ACCORD-BP (Action to Control Cardiovascular Risk in Diabetes Blood Pressure) trial used a double 2×2 factorial design to simultaneously investigate BP, lipid, and glycemic control interventions.</s><s xml:id="_c64W3yv">Participants were randomized to BP goals identical to SPRINT: &lt;120 mm Hg or &lt;140 mm Hg.</s><s xml:id="_VZNMaJA">After one year, there were no differences between the BP treatment groups for the primary composite outcome of nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes (hazard ratio [HR] 0.88, 95% CI 0.73 to 1.06) <ref type="bibr" target="#b26">[27]</ref>.</s><s xml:id="_HMT2k87">However, among ACCORD-BP participants in the standard glycemia treatment arm, targeting an intensive SBP did significantly reduce CVD events similar to the risk reduction observed in SPRINT (HR 0.74; 95% CI 0.55 to 1.00) <ref type="bibr" target="#b27">[28]</ref>.</s><s xml:id="_vvkgaD5">In a post-hoc analysis of SPRINT, the benefits of targeting intensive SBP goals were similar among those with and without prediabetes and were not attenuated by higher serum glucose levels at baseline <ref type="bibr" target="#b28">[29]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_wwG8XaH">Cost-effectiveness of intensive vs. standard BP control</head><p xml:id="_3gyRA4w"><s xml:id="_m9tsYtS">The benefits of targeting intensive SBP goals (e.g., decreased CVD events and improved survival) must be weighed against the potential harms (e.g., serious adverse events [SAE]) and implementation and maintenance costs (e.g., additional office visits, laboratory tests, personnel, and medications).</s><s xml:id="_qyzDRGS">Early CEAs of SPRINT data found intensive SBP goals were cost-effective (Table <ref type="table">1</ref>) <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b30">31]</ref>, but these analyses assumed lifetime persistence of the benefits of intensive control or did not account for costs of treating non-cardiovascular diseases.</s></p><p xml:id="_P5QNkPQ"><s xml:id="_UQKrDxg">A model developed by the SPRINT Research Group estimated healthcare costs and qualityadjusted life years (QALY) gained from targeting intensive versus standard SBP goals in SPRINT-eligible US adults over a lifetime time horizon <ref type="bibr" target="#b31">[32]</ref>.</s><s xml:id="_qPSav7p">The model incorporated decays in medication adherence and treatment effects, a range of treatment costs and office visit frequencies, and varying baseline SAE and CVD event rates.</s><s xml:id="_X5bJtSp">The analysis showed targeting an intensive SBP goal was cost-effective according to accepted cost-effectiveness thresholds regardless of whether treatment benefits decayed or persisted beyond the end of SPRINT follow-up (median follow up 3.26 years) <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b32">33]</ref>.</s><s xml:id="_H46Euam">The incremental cost-effective ratio (ICER) was ~$47,000/QALY gained (2015 USD) for intensive goals relative to standard goals if effects decayed over time, and ~$28,000/QALY gained if treatment effects persisted over a lifetime.</s><s xml:id="_2tNcAMa">A scenario analysis found that the baseline risk of SAEs observed in SPRINT would need to be inflated by a factor of 2.8, or the SAE risk with the intensive treatment alone would need to be increased by a factor of 1.6, in order for the ICER to be greater than $50,000/QALY gained.</s><s xml:id="_hSQzw9Z">Varying the number of office visits per year and medication prices did not significantly impact the results.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_rdJSbBV">Opportunities and challenges</head><p xml:id="_2TpBVWc"><s xml:id="_bK2vPhj">Targeting more-intensive SBP goals is effective and cost-effective in high CVD risk populations, yet applying and implementing intensive goals to the guideline-directed patient population with hypertension represents a deviation from the status quo.</s><s xml:id="_eUK5Hft">Nearly 1 in 3 US adults with treated hypertension have BP greater than previous guideline-recommended targets of &lt;140/90 mm Hg <ref type="bibr" target="#b33">[34]</ref>.</s><s xml:id="_3TyHpW9">As such, more-intensive SBP goals have not been widely adopted by clinicians, health systems, or professional societies.</s></p><p xml:id="_rfUtjnz"><s xml:id="_fax3qgB">Several challenges limit widespread implementation of intensive BP targets.</s><s xml:id="_KqNzZBz">First, in order to attain the lower SBP thresholds as demonstrated in SPRINT, clinical practice would need to mirror both the high-quality measurement of BP and treatment with medications (combinations and doses) used in SPRINT <ref type="bibr" target="#b34">[35]</ref>.</s><s xml:id="_QRhHtRM">In SPRINT, BP was measured three times using an automated device (Omron HEM 907XL) at each clinic visit after a five-minute rest period <ref type="bibr" target="#b35">[36]</ref>, which typically takes 8-10 minutes <ref type="bibr" target="#b36">[37]</ref>.</s><s xml:id="_AkaMGnA">For many clinics and health systems, the real and perceived constraints on space, staffing, and time limit the ability to measure and treat BP as performed under research conditions <ref type="bibr" target="#b37">[38]</ref>.</s></p><p xml:id="_BCCnN7t"><s xml:id="_2hGcJkN">Additionally, targeting more-intensive BP goals has significant implications for medication management.</s><s xml:id="_y3qXE5P">Achieving lower BP may require more medications, improved adherence, higher doses, or all of these.</s><s xml:id="_3q3Bc5W">Patients with hypertension at high risk of CVD events are likely to have multiple comorbidities and high existing medication burden, including nonantihypertensive medications <ref type="bibr" target="#b38">[39]</ref>.</s><s xml:id="_6jZsFQn">Thus, medication adherence, drug interactions, and patient satisfaction and acceptance become important concerns when considering whether to add more antihypertensive medications or increase antihypertensive medication doses.</s><s xml:id="_KUyEe2s">When all else is equal, medication regimens that are less complex (e.g., single-pill combinations, less-frequent daily dosing) should be favored for the benefit of improved medication adherence <ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref>.</s><s xml:id="_Bbsc9tS">The optimal doses and combinations of evidence-based antihypertensive medication classes to achieve intensive goals are unknown.</s><s xml:id="_PGuzYzR">It is even less clear how intensive SBP goals should be broadly applied to treatment decisions in populations that were excluded from SPRINT (e.g., age &lt;50 years, prior diagnosis of diabetes, stroke, or heart failure).</s></p><p xml:id="_rqSVf5z"><s xml:id="_GVfqbTU">Beyond logistics, integrating more-intensive BP goals into clinical practice will be challenging at the prescriber level.</s><s xml:id="_bsutMUY">Clinical inertia, the phenomenon of not initiating or intensifying therapy at the point of care despite a BP reading that is above goal, is highly prevalent in hypertension management <ref type="bibr" target="#b42">[43,</ref><ref type="bibr" target="#b43">44]</ref> and may be a key factor preventing BP control <ref type="bibr" target="#b44">[45]</ref>.</s><s xml:id="_vH9SqTk">Several factors associated with the patient, provider, and system elicit clinical inertia <ref type="bibr" target="#b45">[46]</ref>, such as low health literacy, insufficient provider-patient time, or lack of protocols.</s><s xml:id="_MehJUJ5">Clinical inertia must be distinguished from clinical uncertainty, which may result from variability in BP measurement, poor quality data on medication adherence, or other modifiable factors.</s><s xml:id="_uPDkHWS">Indeed, both clinical inertia and clinical uncertainty may affect the implementation of an appropriate therapeutic regimen, reducing the likelihood of attaining intensive SBP goals.</s></p><p xml:id="_sjaQ2TT"><s xml:id="_wkgKfJr">Nonetheless, improved hypertension treatment and control rates can be achieved.</s><s xml:id="_U4bnhzS">Health systems like Kaiser Permanente and the Department of Veterans Affairs have successfully achieved BP control rates of 80% to standard goals among those with treated hypertension using standardized protocols and TBC <ref type="bibr" target="#b46">[47,</ref><ref type="bibr" target="#b47">48]</ref>.</s><s xml:id="_WgNXYNw">Systematic, durable, multi-faceted interventions are needed to improve hypertension control.</s><s xml:id="_MMGtygB">Using TBC has great potential to expand capacity and mitigate challenges that directly affect BP control rates.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dxZGm2H">Team-based care is more effective than usual care</head><p xml:id="_3uGEQvu"><s xml:id="_EWXpetR">TBC can be delivered with a wide variety models and more effectively lowers BP than usual care <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_VnnzsjN">The types of TBC models studied are diverse and include non-physician provider clinic visits, utilizing non-physician providers (i.e., nurses, nurse practitioners [NP], physician assistants [PA], or pharmacists) to manage hypertension, and optimizing patient education and support personnel <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b48">49,</ref><ref type="bibr" target="#b49">50]</ref>.</s><s xml:id="_RPZSnvN">One recent meta-analysis of over 100 trials and 55,920 patients concluded that the most effective BP-lowering strategies use multilevel, multicomponent approaches to address barriers to hypertension control and often involve non-physician providers assessing the patients, measuring BP and laboratory values, then titrating medications <ref type="bibr" target="#b50">[51]</ref>.</s><s xml:id="_MFvXjhC">Compared with usual care, TBC with non-physician medication titration resulted in a 7.1 mm Hg mean SBP reduction, and TBC with physician medication titration resulted in a 6.2 mm Hg mean SBP reduction.</s><s xml:id="_3Y45wpd">Similar trends were observed with DBP reductions.</s></p><p xml:id="_7fazWhs"><s xml:id="_jwhPNZZ">Pharmacists are widely employed in TBC for hypertension management <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref>.</s><s xml:id="_ZuFB5jh">In one randomized trial of 625 patients, 43% of patients achieved BP control at nine months under pharmacist-physician collaboration, compared to 34% of those participating in usual care <ref type="bibr" target="#b52">[53]</ref>.</s><s xml:id="_UBdK2Sd">In another study of 450 patients, combining pharmacists with telehealth management yielded BP control rates greater than 70%, significantly more than the 45% of participants who achieved BP control via usual care <ref type="bibr" target="#b53">[54]</ref>.</s><s xml:id="_fDZyHxt">Additionally, a pharmacist-led intervention in a community setting for non-Hispanic Black male patrons of barbershops with uncontrolled BP resulted in a mean SBP reduction of 21.6 mm Hg greater than usual care at six months <ref type="bibr" target="#b54">[55]</ref>.</s><s xml:id="_C8sZun7">The effects of pharmacist-provided hypertension care often persist beyond the initial intervention period <ref type="bibr" target="#b55">[56,</ref><ref type="bibr" target="#b56">57]</ref>.</s><s xml:id="_76e9T4E">Strong patient-pharmacist and community relationships in addition to individualized treatment plans have been considered as drivers for these successful interventions <ref type="bibr" target="#b56">[57]</ref><ref type="bibr" target="#b57">[58]</ref><ref type="bibr" target="#b58">[59]</ref>.</s></p><p xml:id="_t4CDj9T"><s xml:id="_cUEm35U">Nurses are also widely used for effective hypertension management in TBC models <ref type="bibr" target="#b59">[60]</ref><ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b61">[62]</ref>.</s><s xml:id="_fuaXHUc">One meta-analysis of national and international studies that stratified results by specific nurse-led interventions found a mean decrease in SBP from baseline of 8.2 mm Hg with nurse management using treatment algorithms, and 8.9 mm Hg with nurse prescribing <ref type="bibr" target="#b61">[62]</ref>.</s><s xml:id="_2wGEx2v">Another meta-analysis of 11 national and international nurse-led interventions to improve BP control in patients with diabetes demonstrated an overall 5.8 mm Hg mean decrease in SBP compared to physician-led care <ref type="bibr" target="#b62">[63]</ref>.</s><s xml:id="_vJv4jHa">Nursing personnel also serve in administrative or leadership positions, liaise between the medical team and the patient, and act as crucial care coordinators in the patient care process.</s></p><p xml:id="_rWby68P"><s xml:id="_K6dmp98">Beyond pharmacist and nurse management, there are several ongoing studies to improve hypertension care using innovative TBC approaches.</s><s xml:id="_fdK8CyH">Notably, the RICH-LIFE (Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone) study will evaluate BP outcomes among underserved patients randomized to usual care compared to a comprehensive team of physicians, care managers, community health workers, pharmacists, and dietitians ().</s><s xml:id="_3CCBUVd">Results from this study may inform future CEA to guide value-based implementation decisions in underserved populations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Gh8RbzF">Team-based care is cost-effective relative to usual care</head><p xml:id="_2YpTMQH"><s xml:id="_hSW2swW">TBC to manage hypertension has been shown to be cost-effective in several analyses (Table <ref type="table" target="#tab_1">2</ref>).</s><s xml:id="_MCBmRW9">These studies can be broadly categorized into formal CEAs (e.g., simulation, Markov modeling) and cost analyses of observational or interventional studies.</s><s xml:id="_wygr4nz">Key findings are highlighted here, as exhaustive reviews and discussions about TBC for hypertension including international studies are provided elsewhere <ref type="bibr" target="#b48">[49,</ref><ref type="bibr" target="#b49">50,</ref><ref type="bibr" target="#b63">64]</ref>.</s></p><p xml:id="_Nn2P6Vd"><s xml:id="_vSb3Pv7">One recent systematic review assessed 34 national and international cost-effectiveness studies of community interventions to manage patients with hypertension, most of which incorporated non-physician providers alone or in conjunction with physician-provided care <ref type="bibr" target="#b63">[64]</ref>.</s><s xml:id="_Z9AfJeb">Among 25 studies that implemented educational interventions for lifestyle and/or medication adherence, the median cost (2014 USD) to lower SBP by 1 mm Hg was $62 (range: $40-$114) with a median ICER of $13,986/QALY gained (range $6,683-$58,610).</s><s xml:id="_YGBamPd">Importantly, the authors noted that community-based interventions for hypertension care are significantly heterogeneous in setting and outcomes studied.</s><s xml:id="_2tKJ2cy">Most studies assessed outcomes at less than one year, and longer follow-up is needed to confidently estimate long-term ICERs.</s><s xml:id="_GQkJDgW">Many of the studies were not randomized or controlled, or the economic analyses did not implement uncertainty or sensitivity analyses.</s><s xml:id="_C8nANAU">Regardless, the findings from this review confirm estimates from a previous systematic review of 31 TBC studies from the US and internationally, which reported a median ICER of $10,511-$15,137/QALY gained (2010 USD) and a median total implementation cost of $355 per patient <ref type="bibr" target="#b64">[65]</ref>.</s></p><p xml:id="_mS2nvZr"><s xml:id="_MCrWCRA">Several cost analyses of pharmacist-provided care models for hypertension management have been published based on results from interventional studies <ref type="bibr" target="#b52">[53,</ref><ref type="bibr" target="#b53">54,</ref><ref type="bibr" target="#b65">66,</ref><ref type="bibr" target="#b66">67]</ref>.</s><s xml:id="_9upKzys">Clinicembedded clinical pharmacists cost $33 (2013 USD) per 1-mm Hg reduction in SBP and $70 per 1-mm Hg reduction in DBP relative to usual care <ref type="bibr" target="#b67">[68]</ref>, similar to 2008 estimates <ref type="bibr" target="#b68">[69]</ref>.</s><s xml:id="_PFNgZST">Combining pharmacist-managed hypertension care with telehealth is slightly more expensive at $139 per 1-mm Hg reduction in SBP and $265 per 1-mm Hg reduction in DBP (2012 USD) <ref type="bibr" target="#b69">[70]</ref>.</s><s xml:id="_jh8P8uD">One economic evaluation found that, assuming an intervention cost of $525 per patient, a pharmacist-delivered hypertension management program could generate 5-year cost-savings in Medicare patients with treated, persistently uncontrolled BP <ref type="bibr" target="#b70">[71]</ref>.</s><s xml:id="_9jBfnek">In one formal CEA, compared to usual care, the ICER for pharmacists to manage hypertension was $26,800 (2015 USD) per QALY gained, and the intervention was broadly cost-effective for the highest risk patients (i.e., comorbid diabetes, smoking, hypercholesterolemia, or obesity) <ref type="bibr" target="#b71">[72]</ref>.</s><s xml:id="_BvaHEpC">At the community pharmacist level, interventions largely focus on improving antihypertensive medication adherence, although results show both cost-savings of more than $6,000 per patient <ref type="bibr" target="#b72">[73,</ref><ref type="bibr" target="#b73">74]</ref> or minimal effectiveness and cost-effectiveness compared to usual care <ref type="bibr" target="#b74">[75,</ref><ref type="bibr" target="#b75">76]</ref>.</s></p><p xml:id="_ryBsPpD"><s xml:id="_pMeqjMD">For a broad range of chronic disease management, the inclusion of nurses and NPs on teams is widely considered cost-effective, especially when added to a team of other qualified healthcare professionals <ref type="bibr" target="#b76">[77]</ref>.</s><s xml:id="_7CtmYm5">The most robust analyses of a nurse-administered telephone education program <ref type="bibr" target="#b77">[78]</ref> demonstrated a lifetime ICER of $87,300 per life-year (LY) gained for normal-weight males and $43,600/LY gained for overweight males compared to usual care <ref type="bibr" target="#b78">[79]</ref>.</s><s xml:id="_pxeyWsN">Including direct and indirect costs, the mean cost to deliver the intervention was $112 per patient, with a range of $61 to $259 depending on salary, number of patients managed, and types of indirect costs.</s><s xml:id="_snahZ8d">In another analysis, combining an NP and community health worker to manage CVD risk factors demonstrated that for every one-mm Hg reduction in SBP and DBP, the intervention cost $101 and $209 (2010 USD), respectively, compared to usual care <ref type="bibr" target="#b79">[80]</ref>.</s><s xml:id="_uApzJZz">More economic and CEA data specific to NP-delivered hypertension care are needed to guide implementation decisions by health systems.</s></p><p xml:id="_cgSCVRE"><s xml:id="_pGPv4h8">The variation in models for pharmacist-and nurse-delivered interventions for hypertension care hampers definitive conclusions on the cost-effectiveness of TBC.</s><s xml:id="_TdHH8Mc">Given that TBC is effective and recommended by current clinical practice guidelines, formal CEAs that compare TBC strategies to one another rather than usual care are needed.</s><s xml:id="_2zykPeS">Additionally, no CEA has assessed the cost-effectiveness of TBC strategies specifically to achieve the moreintensive SBP goals recommended by the 2017 ACC/AHA guidelines.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5XbsMB6">Opportunities and challenges preventing widespread adoption of TBC to manage hypertension</head><p xml:id="_U8R73E2"><s xml:id="_eAs2VYZ">There are numerous opportunities to increase adoption of TBC in hypertension, but not without challenges.</s><s xml:id="_gZfXHgK">First, scopes of practice for non-physician providers (e.g., nurses and pharmacists) are managed by country or state laws, thereby dictating the degree to which non-physician providers can be integrated into clinical practice <ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_v3GBfpm">Laws differ in required physician oversight, allowable activities (e.g., medication prescribing, laboratory ordering), and protocol requirements <ref type="bibr" target="#b80">[81]</ref>.</s><s xml:id="_W8UvmbJ">Billing and reimbursement practices also vary, which are key institutional considerations in assessing the financial feasibility to hire a new employee.</s><s xml:id="_6hcMVJc">For example, pharmacists are not currently recognized as healthcare providers by Medicare in the United States, which is frequently cited by state-based programs and insurance carriers as a justification for limiting reimbursement for pharmacist-provided services <ref type="bibr" target="#b81">[82,</ref><ref type="bibr" target="#b82">83]</ref>.</s><s xml:id="_dFqSvvR">The utilization and optimization of non-physician providers is crucial to public health.</s><s xml:id="_ay6f674">Current U.S.-based estimates project a shortage of over 40,000 primary care practitioners by 2030 <ref type="bibr" target="#b84">[84]</ref>.</s><s xml:id="_2krnCeJ">There are also opportunities for including supportive healthcare personnel, such as certified nursing assistants, medical assistants, or pharmacy technicians and interns, but specific roles have yet to be delineated or evaluated formally.</s></p><p xml:id="_fw3R23z"><s xml:id="_HnH2pfw">In low-and middle-income countries (LMIC), integration of TBC for hypertension management is met with additional high-level systems barriers.</s><s xml:id="_AuvyaQf">Several competing acute healthcare, political, and social concerns may impede funding and focus for improving chronic disease management <ref type="bibr" target="#b86">[85]</ref>.</s><s xml:id="_7kxqTmP">Examples include infectious diseases (e.g., malaria), armed conflict, or access to family planning services.</s><s xml:id="_P9n4fdH">From a funding perspective, the status quo of funding "vertical" interventions which target specific populations or diseases challenges the shift to fund "horizontal" interventions which focus on comprehensive, system-based solutions such as primary health care <ref type="bibr" target="#b87">[86]</ref>.</s><s xml:id="_z5PQ3wZ">A three-round panel consultation with 141 experts from 50 LMIC identified the horizontal integration of multidisciplinary teams as a priority area to improve health care <ref type="bibr" target="#b88">[87]</ref>.</s><s xml:id="_FYDbdCa">Depending on country-specific laws and regulations for healthcare professionals, utilization of diverse members of the healthcare team with strong community linkages will likely be required to develop effective and sustainable care delivery models for hypertension management in LMIC <ref type="bibr" target="#b89">[88]</ref>.</s></p><p xml:id="_h4vcvB3"><s xml:id="_sPDt6Dm">Health systems bear the cost burdens of implementing and maintaining TBC.</s><s xml:id="_aaKjWCx">Cost decisions are influenced by available funds, perceived or actual relative value, alignment with the organization's mission and vision, feasibility of implementation, capacity for risk management and administrative support, and estimates for return on investment.</s><s xml:id="_6yXyVMp">The most effective, efficient, and feasible method for implementing TBC has yet to be determined and likely varies by practice setting, patient population, and geographic region.</s><s xml:id="_469Nbzb">Given the minimal up-front costs, serious sequalae associated with uncontrolled hypertension, and effectiveness of TBC, health systems should invest in TBC with the long-term goals of improving patient outcomes and satisfaction with hypertension care.</s></p><p xml:id="_6PPNvT9"><s xml:id="_wEZCUVA">New technology, such as smart phone apps, wearables, and Bluetooth-enabled home BP monitors may augment TBC for the management of hypertension.</s><s xml:id="_JDH3Hdf">Technology allows for quick transmission of information, such as home BP readings, to the hypertension management team.</s><s xml:id="_dubmu9x">Hypertension care can be integrated with electronic patient portals, telehealth programs, or wearable products (e.g., Fitbit™).</s><s xml:id="_HnhwaK6">In fact, titrating medications according to BP measurements assessed via telemonitoring has shown to be effective and cost-effective compared to usual care, particularly when combining self-monitoring with TBC interventions <ref type="bibr" target="#b90">[89]</ref><ref type="bibr" target="#b91">[90]</ref><ref type="bibr" target="#b92">[91]</ref>.</s><s xml:id="_vP2KqKs">Future research could incorporate patient-reported outcomes and measure the impact of technology on patient engagement, acceptance, and satisfaction.</s><s xml:id="_UcRBgRS">From the patient perspective, some technology may be cost-prohibitive, which must be considered when deciding whether and how to implement certain telehealth services.</s><s xml:id="_EYG5Tuw">Technology will undoubtedly play a crucial role to manage hypertension in patients who may not be as accessible to healthcare providers, such as those who are bedridden, live in rural areas, work during clinic hours, or struggle with access to reliable transportation.</s></p><p xml:id="_gGesYDT"><s xml:id="_yMTdQhe">Patient acceptance and engagement are critical to effectively manage hypertension.</s><s xml:id="_aDdastA">Patients ultimately share responsibility for their daily hypertension management including home BP monitoring, lifestyle modifications, and antihypertensive medication adherence.</s><s xml:id="_WJqUQcP">Unfortunately, antihypertensive medication non-adherence remains common, found in approximately 45% of treated patients, and increases with the prevalence of uncontrolled BP <ref type="bibr" target="#b93">[92,</ref><ref type="bibr" target="#b94">93]</ref>.</s><s xml:id="_UcYhyTA">Adherence to various non-pharmacologic lifestyle modifications to reduce BP is even lower <ref type="bibr" target="#b95">[94]</ref>.</s><s xml:id="_4bQwmv5">High-quality data on the effectiveness of interventions to support shared decision-making for hypertension management are lacking <ref type="bibr" target="#b96">[95,</ref><ref type="bibr" target="#b97">96]</ref>.</s><s xml:id="_NfZQUWg">Successful strategies for sustaining patient engagement in various TBC interventions are needed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ZTVywUC">Conclusion</head><p xml:id="_BUEYKQ5"><s xml:id="_vBM9Hzf">Intensive therapy for SBP is an effective and cost-effective intervention to prevent complications from hypertension.</s><s xml:id="_CCGn5SJ">Team-based care that includes non-physician providers to manage hypertension is more effective than usual care and will become increasingly important to achieve and maintain intensive SBP goals at scale.</s><s xml:id="_SnVPXGj">TBC strategies have been shown to be cost-effective compared to usual care.</s><s xml:id="_zPjh4Fk">Research is needed to evaluate the efficacy and cost-effectiveness of several team-based care interventions relative to one another to achieve widespread intensive BP control targets.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7NnhFef">Sources of Funding:</head><p xml:id="_my9aGHx"><s xml:id="_sVkxZ2V">This manuscript was supported in part by 5R01HL139837-02 from the NHLBI (PI: Weintraub, Moran, Bress).</s><s xml:id="_TAbKxU7">Dr. Derington is supported by American Heart Association Grant #19POST34380226/Derington/2019.</s><s xml:id="_zBTKC3a">Dr. Bress is supported by K01HL133468 from the NHLBI.</s><s xml:id="_w9QC9ZE">Dr. Moran is supported by R01HL130500-01A1 from the NHLBI.</s><s xml:id="_77kRvjY">Dr. Bellows is supported by K01-HL140170 from the NHLBI.</s><s xml:id="_qJpFeRk">Dr. Bryant is supported by T32HP10260 from HRSA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jaGRsug">Table 1:</head><p xml:id="_snBR8Za"><s xml:id="_hQWVcqb">Studies assessing the cost-effectiveness of intensive systolic blood pressure control</s></p><p xml:id="_Zds4fkW"><s xml:id="_Zb7AzPN">Author (Year) [Reference] Country Comparators Clinical inputs Model Description Costs considered Time Horizon Perspective Base Case ICER Moise (2016) [30] United States JNC8 Guideline strategies alone * vs. Guideline-directed strategies * + "Intensive" strategy to SBP &lt;120 mm Hg in select groups CVD Policy Model + SPRINT Markov model Background health care, acute and chronic CVD, medications, monitoring, side effects Lifetime Payer Men Cost-saving for both guidelines +intensive Women Cost-saving for JNC8+intensive $21,000 2016 USD per QALY gained for JNC7+intensive strategy Richman (2016) [31] United States SBP &lt;140 mm Hg vs. SBP &lt;120 mm Hg SPRINT Markov model Background medical costs, acute and chronic CVD events, medications, physician visits, adverse events Lifetime Not reported $23,777 2016 USD per QALY gained Lee (2016) [98] Korea SBP &lt;140 mm Hg vs. SBP &lt;120 mm Hg SPRINT "Decision model" Medications, CVD events Not reported Not reported 2,513,799 Korean won ($ 2,302 2014 USD † ) per QALY gained Bress and Bellows (2017) [32] United States SBP &lt;140 mm Hg vs. BP &lt;120 mm Hg SPRINT Microsimulation Medications, office visits, laboratory monitoring, acute and chronic CVD, adverse events, background non-CVD health care Lifetime Payer $46,546 2017 USD per QALY gained Abbreviations: CVD: Cardiovascular Disease; ICER: Incremental Cost-Effectiveness Ratio; JNC7: Seventh Joint National Committee; JNC8: Eighth Joint National Committee; QALY: Quality-Adjusted</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 :</head><label>2</label><figDesc><div><p xml:id="_eaTPMER"><s xml:id="_E3n9xG7">Studies assessing cost outcomes of team-based care models for hypertension management in the US (selected recent studies)</s></p></div></figDesc><table><row><cell>Notes</cell><cell></cell><cell></cell><cell></cell><cell>Did not incorporate</cell><cell>patient preferences or</cell><cell>utility values</cell><cell></cell><cell></cell><cell>Did not incorporate</cell><cell>patient preferences or</cell><cell cols="2">utility values</cell><cell></cell><cell></cell><cell></cell><cell>Did not incorporate</cell><cell>patient preferences or</cell><cell>utility values</cell><cell></cell><cell></cell><cell></cell><cell>Base case assumed</cell><cell>one-time, 6-month</cell><cell>intervention with</cell><cell>sustained effects for</cell><cell>up to 2 years, then</cell><cell>deterioration of effects</cell><cell>thereafter</cell><cell>Did not incorporate</cell><cell>patient preference or</cell><cell>utility values</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Did not incorporate</cell><cell>patient preference or</cell><cell>utility values</cell></row><row><cell>Base Case ICER or Main</cell><cell>Results</cell><cell></cell><cell></cell><cell>Intervention cost $33 (2013</cell><cell>USD) per 1-mm Hg</cell><cell>reduction in SBP and $70</cell><cell>per 1-mm Hg reduction in</cell><cell>DBP relative to usual care.</cell><cell>Intervention cost $139 (2012</cell><cell>USD) per 1-mm Hg</cell><cell cols="2">reduction in SBP and $265</cell><cell cols="2">per 1-mm Hg reduction in</cell><cell>DBP relative to usual care</cell><cell>Intervention cost $36 (2008</cell><cell>USD) per 1-mm Hg</cell><cell>reduction in SBP and $94</cell><cell>per 1-mm Hg reduction in</cell><cell>DBP relative to usual care</cell><cell></cell><cell>Lifetime: $26,807.83 (2015</cell><cell>USD) per QALY gained</cell><cell>5 years: $78,547.07 per</cell><cell>QALY gained</cell><cell>10 years: $39,084.65 per</cell><cell>QALY gained</cell><cell></cell><cell>Men</cell><cell>Normal weight: $87,300 per</cell><cell>LY gained</cell><cell>Overweight: $43,567 per LY</cell><cell>gained</cell><cell>Women</cell><cell>Normal weight: $42,457 per</cell><cell>LY gained</cell><cell>Overweight: $58,560 per LY</cell><cell>gained</cell><cell>Intervention cost $101 (2010</cell><cell>USD) per 1-mm Hg</cell><cell>reduction in SBP and $209</cell><cell>per 1-mm Hg reduction in</cell><cell>DBP relative to usual care</cell></row><row><cell>Perspective</cell><cell></cell><cell></cell><cell></cell><cell>"Society in</cell><cell>general"</cell><cell></cell><cell></cell><cell></cell><cell>Health care</cell><cell>sector</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Not reported</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Payer</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Payer</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>"Health</cell><cell>services"</cell></row><row><cell>Time</cell><cell>Horizon</cell><cell>or Follow-</cell><cell>up Period</cell><cell>9 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>12 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>6 months</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Lifetime</cell><cell>5 years</cell><cell>10 years</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>2 years</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>12 months</cell></row><row><cell>Costs considered</cell><cell></cell><cell></cell><cell></cell><cell>Physician time,</cell><cell>pharmacist time,</cell><cell>medications</cell><cell></cell><cell></cell><cell>Outpatient chronic</cell><cell cols="2">management * , acute</cell><cell cols="2">care management * ,</cell><cell cols="2">medications</cell><cell>Provider time,</cell><cell>pharmacist time,</cell><cell>specialist time,</cell><cell>laboratory tests,</cell><cell>medications, overhead</cell><cell>costs</cell><cell>Provider time,</cell><cell>pharmacist time,</cell><cell>specialist time, acute</cell><cell>and chronic CVD,</cell><cell>laboratory tests,</cell><cell>medications</cell><cell></cell><cell>Intervention costs</cell><cell>(nurse time, supplies),</cell><cell>variable indirect costs,</cell><cell>resource utilization</cell><cell>costs,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>NP and CHW time,</cell><cell>laboratory tests,</cell><cell>medications</cell></row><row><cell>Clinical inputs Model</cell><cell>[Reference] Description</cell><cell></cell><cell></cell><cell>CAPTION [53] N/A</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Hyperlink [54] N/A</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Pooled two N/A</cell><cell>cluster</cell><cell>randomized</cell><cell>trials [66,99]</cell><cell></cell><cell></cell><cell>Pooled two Markov</cell><cell>cluster model</cell><cell>randomized</cell><cell>trials [66,99]</cell><cell></cell><cell></cell><cell></cell><cell>V-STITCH Monte Carlo</cell><cell>[78] Simulation</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>COACH [100] N/A</cell></row><row><cell>Author (Year) Comparators</cell><cell>[Reference]</cell><cell></cell><cell>Pharmacist Interventions</cell><cell>Polgreen (2015) Clinical pharmacist</cell><cell>[68] providing real-time</cell><cell>recommendations to</cell><cell>provider vs. usual care</cell><cell></cell><cell>Dehmer (2018) Clinical pharmacist</cell><cell>[70] telehealth management</cell><cell cols="2">vs. usual care</cell><cell></cell><cell></cell><cell></cell><cell>Kulchaitanaroaj Clinical pharmacist-</cell><cell>(2012) [69] physician collaboration</cell><cell>vs. usual care</cell><cell></cell><cell></cell><cell></cell><cell>Kulchaitanaroaj Clinical pharmacist-</cell><cell>(2017) [72] physician collaboration</cell><cell>vs. usual care</cell><cell></cell><cell></cell><cell></cell><cell>Nurse Interventions</cell><cell>Datta (2010) [79] Nurse-led behavioral</cell><cell>intervention vs. usual</cell><cell>care</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Allen (2014) [80] NP/CHW management</cell><cell>vs. usual care</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_cdgajKf"><s xml:id="_wRAAjVJ">Curr Hypertens Rep. Author manuscript; available in PMC 2019 November 22.</s></p></note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SKDZ4rN">Author (Year)</head><p xml:id="_6R9qDXn"><s xml:id="_7zYS3Db">[Reference]</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Vqj6zgz">Comparators</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_s9g9n6R">Clinical inputs [Reference]</head><note type="other" xml:id="_fvVtrJy">Model</note></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_7jzAAnK">The Elusiveness of Population-Wide High Blood Pressure Control</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Whelton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sVxGTHA">Annu Rev Public Heal</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="109" to="130" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Whelton PK. The Elusiveness of Population-Wide High Blood Pressure Control. Annu Rev Public Heal. 2015;36:109-30.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_7ZUzGwz">Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies</title>
		<author>
			<orgName type="collaboration">Prospective Studies Collaboration</orgName>
		</author>
		<idno type="PMID">12493255</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EtTSm3j">Lancet</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="page" from="1903" to="1913" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-13. [PubMed: 12493255]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_JcqzpT2">A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Flaxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Danaei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shibuya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Adair-Rohani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cuZ2WZS">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="2224" to="2260" />
			<date type="published" when="2010">2010. 2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2224-60.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_gVUFmc6">Heart Disease and Stroke Statistics -2019 Update: A Report from the American Heart Association</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Benjamin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Muntner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Alonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Bittencourt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Callaway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Carson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6YsWegV">Circulation</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="0" to="00" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics -2019 Update: A Report from the American Heart Association. Circulation. 2019;139:00-00.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_9jktYR2">ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Whelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Carey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Aronow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Casey</forename><surname>De</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dennison</forename><surname>Himmelfarb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<idno type="PMID">29146535</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RmP7T5m">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="e127" to="248" />
			<date type="published" when="2015">2015. 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2015 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P. J Am Coll Cardiol. 2018;71:e127-248. [PubMed: 29146535]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_36WS36H">Hypertension-A Public Health Challenge of Global Proportions</title>
		<author>
			<persName><forename type="first">Ndl</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Curfman</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2018.16760</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uDCGNRP">JAMA</title>
		<imprint>
			<biblScope unit="volume">320</biblScope>
			<biblScope unit="page">17571759</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fisher NDL, Curfman G. Hypertension-A Public Health Challenge of Global Proportions. JAMA. 2018;320:17571759.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_tdaQTRt">ACC health policy statement on cardiovascular team-based care and the role of advanced practice providers</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Brush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Handberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Biga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Birtcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Bove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Casale</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2015.03.550</idno>
		<idno type="PMID">25975476</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VWX5ree">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="2118" to="2136" />
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brush JE, Handberg EM, Biga C, Birtcher KK, Bove AA, Casale PN, et al. 2015 ACC health policy statement on cardiovascular team-based care and the role of advanced practice providers. J Am Coll Cardiol. 2015;65:2118-36. [PubMed: 25975476]</note>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<ptr target="https://www.cdc.gov/dhdsp/pubs/guides/best-practices/team-based-care.htm" />
		<title level="m" xml:id="_QNhuMF8">Best Practices for Cardiovascular Disease Prevention Programs: A Guide to Effective Health Care System Interventions and Community Programs Linked to Clinical Services, Promoting Team-Based Care to Improve High Blood Pressure Control</title>
		<meeting><address><addrLine>Atlanta, GA</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
		<respStmt>
			<orgName>Centers for Disease Control and Prevention</orgName>
		</respStmt>
	</monogr>
	<note>Internet</note>
	<note type="raw_reference">Centers for Disease Control and Prevention. Best Practices for Cardiovascular Disease Prevention Programs: A Guide to Effective Health Care System Interventions and Community Programs Linked to Clinical Services, Promoting Team-Based Care to Improve High Blood Pressure Control [Internet]. Atlanta, GA; 2017 Available from: https://www.cdc.gov/dhdsp/pubs/guides/best- practices/team-based-care.htm</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_V2JbX6a">The Triple Aim: Care, Health, And Cost</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Berwick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Nolan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Whittington</surname></persName>
		</author>
		<idno type="DOI">10.1377/hlthaff.27.3.759</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RC4KTpM">Health Aff</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="759" to="769" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Berwick DM, Nolan TW, Whittington J. The Triple Aim: Care, Health, And Cost. Health Aff. 2008;27:759-69.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_he9FtQs">Commentary Measuring the Triple Aim: A Call for Action</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stiefel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nolan</surname></persName>
		</author>
		<ptr target="www.liebertpub.com" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_DhZSUNy">Popul Health Manag</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="219" to="220" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Internet cited 2019 Jun 27</note>
	<note type="raw_reference">Stiefel M, Nolan K. Commentary Measuring the Triple Aim: A Call for Action. Popul Health Manag [Internet]. 2013 [cited 2019 Jun 27];16:219-20. Available from: www.liebertpub.com</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_AHUKA4X">Successes of a National Study of the Chronic Disease Self-Management Program</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Ory</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Ritter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Whitelaw</surname></persName>
		</author>
		<idno type="DOI">10.1097/mlr.0b013e3182a95dd1</idno>
		<idno type="PMID">24113813</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mT9g2TK">Med Care</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="992" to="998" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ory MG, Ahn S, Jiang L, Smith ML, Ritter PL, Whitelaw N, et al. Successes of a National Study of the Chronic Disease Self-Management Program. Med Care. 2013;51:992-8. [PubMed: 24113813]</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_Hck7fHu">Team-Based Care and Improved Blood Pressure Control: A Community Guide Systematic Review</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Proia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Thota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Njie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rkc</forename><surname>Finnie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Hopkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Mukhtar</surname></persName>
		</author>
		<idno type="PMID">24933494</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_m6BxNZD">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="86" to="99" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Proia KK, Thota AB, Njie GJ, Finnie RKC, Hopkins DP, Mukhtar Q, et al. Team-Based Care and Improved Blood Pressure Control: A Community Guide Systematic Review. Am J Prev Med. 2014;47:86-99. [PubMed: 24933494]</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_GfCPZZ8">Patient Perceptions of the Quality of Health Services</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sofaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Firminger</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev.publhealth.25.050503.153958</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wxH9YpP">Annu Rev Public Heal</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="513" to="559" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sofaer S, Firminger K. Patient Perceptions of the Quality of Health Services. Annu Rev Public Heal. 2005;26:513-59.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_PCAfDwX">Why Don&apos;t Americans Use Cost-Effectiveness Analysis?</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Neumann</surname></persName>
		</author>
		<idno type="PMID">15152700</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hv9jCC7">Am J Manag Care</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="308" to="312" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Neumann PJ. Why Don&apos;t Americans Use Cost-Effectiveness Analysis? Am J Manag Care. 2004;10:308-12. [PubMed: 15152700]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_6pgsjt8">ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Heidenreich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Barnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Creager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Fonarow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Gibbons</surname></persName>
		</author>
		<idno type="DOI">10.1161/cir.0000000000000042</idno>
		<idno type="PMID">24677315</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HC5c96Y">Circulation</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="2329" to="2345" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Anderson JL, Heidenreich PA, Barnett PG, Creager MA, Fonarow GC, Gibbons RJ, et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. Circulation. 2014;129:2329-45. [PubMed: 24677315]</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_24H56fD">AHA/ACC/ AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Grundy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Beam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Birtcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Blumenthal</surname></persName>
		</author>
		<idno type="DOI">10.1161/cir.0000000000000698</idno>
		<idno type="PMID">30586774</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qCuEkXt">Circulation</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="1082" to="1143" />
			<date type="published" when="2018">2018. 2019</date>
		</imprint>
	</monogr>
	<note>AHA/ACC guidelines on cholesterol management that incorporates cost-effectiveness analysis into recommendations for PCSK9 use</note>
	<note type="raw_reference">Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/ AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082-143. [PubMed: 30586774] * 2018 AHA/ACC guidelines on cholesterol management that incorporates cost-effectiveness analysis into recommendations for PCSK9 use.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_MBHCrVJ">Cost-Effectiveness of PCSK9 inhibitor therapy in patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Kazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Moran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Coxson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Penko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Ollendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Pearson</surname></persName>
		</author>
		<idno type="PMID">27533159</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SBRRuw3">JAMA</title>
		<imprint>
			<biblScope unit="volume">316</biblScope>
			<biblScope unit="page" from="743" to="753" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kazi DS, Moran AE, Coxson PG, Penko J, Ollendorf DA, Pearson SD, et al. Cost-Effectiveness of PCSK9 inhibitor therapy in patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease. JAMA. 2016;316:743-53. [PubMed: 27533159]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_fDu3YGW">Updated costeffectiveness analysis of PCSK9 inhibitors based on the results of the FOURIER trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Kazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Penko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Coxson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Moran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Ollendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Tice</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UYfEfm4">JAMA -J Am Med Assoc</title>
		<imprint>
			<biblScope unit="volume">318</biblScope>
			<biblScope unit="page" from="748" to="750" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kazi DS, Penko J, Coxson PG, Moran AE, Ollendorf DA, Tice JA, et al. Updated cost- effectiveness analysis of PCSK9 inhibitors based on the results of the FOURIER trial. JAMA -J Am Med Assoc. 2017;318:748-50.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_mSFrUus">Cost, Quality and Chronic Disease: Cost Implications of Improving Blood Pressure Management among U.S. Adults</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Nuckols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Aledort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M-H</forename><surname>Go</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Keesey</surname></persName>
		</author>
		<idno type="PMID">21306365</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BJCMan8">Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1124" to="1157" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nuckols TK, Aledort JE, Adams J, Lai J, Go M-H, Keesey J, et al. Cost, Quality and Chronic Disease: Cost Implications of Improving Blood Pressure Management among U.S. Adults. Health Serv Res. 2011;46:1124-1157. [PubMed: 21306365]</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_Nha7nT8">Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes</title>
		<author>
			<persName><forename type="first">Cost-Effectiveness</forename><surname>Cdc Diabetes</surname></persName>
		</author>
		<author>
			<persName><surname>Group</surname></persName>
		</author>
		<idno type="PMID">12020335</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NPcGjh2">JAMA</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="page" from="2542" to="2551" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287:2542-51. [PubMed: 12020335]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_KuGfPux">Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Moran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Odden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thanataveerat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Tzong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Guzman</surname></persName>
		</author>
		<idno type="PMID">25629742</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CChUh9U">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="447" to="455" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moran AE, Odden MC, Thanataveerat A, Tzong KY, Rasmussen PW, Guzman D, et al. Cost- Effectiveness of Hypertension Therapy According to 2014 Guidelines. N Engl J Med. 2015;372:447-55. [PubMed: 25629742]</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_XydANzv">Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Bundy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Stuchlik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Bu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">N</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Mills</surname></persName>
		</author>
		<idno type="PMID">28564682</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YqqZfCy">JAMA Cardiol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="775" to="781" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bundy JD, Li C, Stuchlik P, Bu X, Kelly TN, Mills KT, et al. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality. JAMA Cardiol. 2017;2:775-81. [PubMed: 28564682]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_K5TUFGm">Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and metaanalysis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ettehad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Emdin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kiran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Callender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Emberson</surname></persName>
		</author>
		<idno type="PMID">26724178</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pr8NgzV">Lancet</title>
		<imprint>
			<biblScope unit="volume">387</biblScope>
			<biblScope unit="page" from="957" to="967" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta- analysis. Lancet. 2016;387:957-67. [PubMed: 26724178]</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_4yWbSra">Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bangalore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Toklu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gianos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schwartzbard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Weintraub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ogedegbe</surname></persName>
		</author>
		<idno type="PMID">28109971</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Z6d3dxs">Am J Med</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="707" to="719" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bangalore S, Toklu B, Gianos E, Schwartzbard A, Weintraub H, Ogedegbe G, et al. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials. Am J Med. 2017;130:707-19. [PubMed: 28109971]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_hwNxrWQ">A Randomized Trial of Intensive versus Standard Blood-Pressure Control</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Wright</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Williamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Whelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Roccoo</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa1511939</idno>
		<idno type="PMID">26551272</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_R53RTdE">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope unit="page" from="2103" to="2116" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wright JT Jr., Williamson J, Whelton P, Snyder J, Sink K, Roccoo M, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373:2103-16. [PubMed: 26551272]</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_yRJDNhu">Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT Intensive Blood Pressure Regimen in the United States: Projections From NHANES</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Bress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Khatib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beddhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hess</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.116.025322</idno>
		<idno type="PMID">28193605</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wrMbu3T">Circulation</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="1617" to="1628" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bress AP, Kramer H, Khatib R, Beddhu S, Cheung AK, Hess R, et al. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT Intensive Blood Pressure Regimen in the United States: Projections From NHANES. Circulation. 2017;135:1617-28. [PubMed: 28193605]</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_jrxSzhx">Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Cushman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Byington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Goff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Grimm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cutler</surname></persName>
		</author>
		<idno type="PMID">20228401</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ENTuF6H">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">362</biblScope>
			<biblScope unit="page" from="1575" to="1585" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cushman WC, Evans GW, Byington RP, Goff DC, Grimm RH, Cutler JA, et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med. 2010;362:1575-85. [PubMed: 20228401]</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_m4EwMbc">Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Margolis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Buse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Cushman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename></persName>
		</author>
		<idno type="PMID">24595629</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FzP83j7">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1721" to="1728" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Margolis KL, O&apos;Connor PJ, Morgan TM, Buse JB, Cohen RM, Cushman WC, et al. Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial. Diabetes Care. 2014;37:1721-8. [PubMed: 24595629]</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_MUDS7Wb">Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Bress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Kreider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beddhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Simmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Cheung</surname></persName>
		</author>
		<idno type="DOI">10.2337/dci17-0061</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WARs9Km">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1401" to="1408" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bress AP, King JB, Kreider KE, Beddhu S, Simmons DL, Cheung AK, et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care. 2017;40:1401-8.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_k664KAU">Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35-74 years: The cardiovascular disease policy model</title>
		<author>
			<persName><forename type="first">N</forename><surname>Moise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kohli-Lynch</forename><surname>Ciaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tzong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Coxson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.115.06814</idno>
		<idno type="PMID">27181996</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NP8HebD">Hypertension</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="88" to="96" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moise N, Huang C, Rodgers A, Kohli-Lynch Ciaran N, Tzong KY, Coxson PG, et al. Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35-74 years: The cardiovascular disease policy model. Hypertension. 2016;68:88-96. [PubMed: 27181996]</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_bGbBpyG">Costeffectiveness of Intensive Blood Pressure Management</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Richman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fairley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Jørgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schuler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Owens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Goldhaber-Fiebert</surname></persName>
		</author>
		<idno type="PMID">27627731</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YexSCv3">JAMA Cardiol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="872" to="879" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Richman IB, Fairley M, Jørgensen ME, Schuler A, Owens DK, Goldhaber-Fiebert JD. Cost- effectiveness of Intensive Blood Pressure Management. JAMA Cardiol. 2016;1:872-9. [PubMed: 27627731]</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_Hs6vGtn">Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Bress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Bellows</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beddhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="PMID">28834469</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HBCjt9r">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">377</biblScope>
			<biblScope unit="page" from="745" to="755" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>Cost-effectiveness analysis of intensive versus standard blood pressure control performed by the SPRINT Research Group</note>
	<note type="raw_reference">Bress AP, Bellows BK, King JB, Hess R, Beddhu S, Zhang Z, et al. Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2017;377:745-55. [PubMed: 28834469] ** Cost-effectiveness analysis of intensive versus standard blood pressure control performed by the SPRINT Research Group.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_WQpwBds">Updating Cost-Effectiveness -the Curious Resilience of the $50,000-per-QALY Threshold</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Weinstein</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmp1405158</idno>
		<idno type="PMID">25162885</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wBQZrk5">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">371</biblScope>
			<biblScope unit="page" from="796" to="797" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Neumann PJ, Cohen JT, Weinstein MC. Updating Cost-Effectiveness -the Curious Resilience of the $50,000-per-QALY Threshold. N Engl J Med. 2014;371:796-7. [PubMed: 25162885]</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_xgH5DHE">Trends in Blood Pressure Among Adults With Hypertension: United States, 2003 to 2012</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nwankwo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Burt</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.114.04012</idno>
		<idno type="PMID">25399687</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3xmMFpv">Hypertension</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="54" to="61" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yoon SS, Gu Q, Nwankwo T, Wright JD, Hong Y, Burt V. Trends in Blood Pressure Among Adults With Hypertension: United States, 2003 to 2012. Hypertension. 2015;65:54-61. [PubMed: 25399687]</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_vC5qJJC">Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT)</title>
		<author>
			<persName><forename type="first">R</forename><surname>Agarwal</surname></persName>
		</author>
		<idno type="PMID">28159816</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_taF3ak8">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">4536</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Agarwal R Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT). J Am Heart Assoc. 2017;6:e004536. [PubMed: 28159816]</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_3kzhdgV">Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial) SPRINT Trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Whelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Cushman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cutler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Snyder</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.117.10479</idno>
		<idno type="PMID">29531173</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vMRGhKU">Hypertension</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="848" to="587" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Johnson KC, Whelton PK, Cushman WC, Cutler JA, Evans GW, Snyder JK, et al. Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial) SPRINT Trial. Hypertension. 2018;71:848-587. [PubMed: 29531173]</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_FPPmhyf">BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Drawz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Ix</surname></persName>
		</author>
		<idno type="DOI">10.1681/asn.2017070753</idno>
		<idno type="PMID">29051347</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_x8emuUd">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="383" to="388" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Drawz PE, Ix JH. BP Measurement in Clinical Practice: Time to SPRINT to Guideline- Recommended Protocols. J Am Soc Nephrol. 2018;29:383-8. [PubMed: 29051347]</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_BZBRDP8">Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel</title>
		<author>
			<persName><forename type="first">P</forename><surname>Muntner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Einhorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Cushman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Whelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Bello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Drawz</surname></persName>
		</author>
		<idno type="PMID">30678763</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qsfDJAM">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="317" to="335" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Muntner P, Einhorn PT, Cushman WC, Whelton PK, Bello NA, Drawz PE, et al. Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73:317-35. [PubMed: 30678763]</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_UpF4Da7">Multimorbidity in Older Adults With Cardiovascular Disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Forman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Maurer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brindis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Salive</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mcfarland</forename><surname>Horne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
		<idno type="PMID">29747836</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mE5dwdQ">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="2149" to="2161" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Forman DE, Maurer MS, Boyd C, Brindis R, Salive ME, Mcfarland Horne F, et al. Multimorbidity in Older Adults With Cardiovascular Disease. J Am Coll Cardiol. 2018;71:2149-61. [PubMed: 29747836]</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_k5puht8">Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Derington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Gums</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Bress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Herrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Greene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Moran</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.119.12907</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_P8ssmU3">Hypertension</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="0" to="00" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note>E-pub ahead of print</note>
	<note type="raw_reference">Derington CG, Gums TH, Bress AP, Herrick JS, Greene TH, Moran AE, et al. Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT. Hypertension. 2019;74:00-00 [E-pub ahead of print].</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_TnhefWc">Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bangalore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kamalakkannan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Parkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Messerli</surname></persName>
		</author>
		<idno type="PMID">17679131</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VkUGQZG">Am J Med</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="713" to="719" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis. Am J Med. 2007;120:713-9. [PubMed: 17679131]</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_URvM8uG">Dosing Frequency and Medication Adherence in Chronic Disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Coleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Limone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Sobieraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kaur</surname></persName>
		</author>
		<idno type="DOI">10.18553/jmcp.2012.18.7.527</idno>
		<idno type="PMID">22971206</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tqYZCTu">J Manag Care Pharm</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="527" to="539" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Coleman CI, Limone B, Sobieraj DM, Lee S, Roberts MS, Kaur R, et al. Dosing Frequency and Medication Adherence in Chronic Disease. J Manag Care Pharm. 2012;18:527-39. [PubMed: 22971206]</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_NeeG97e">The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review</title>
		<author>
			<persName><forename type="first">J-P</forename><surname>Lebeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-S</forename><surname>Cadwallader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Aubin-Auger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mercier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pasquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rusch</surname></persName>
		</author>
		<idno type="PMID">24989986</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bTcMr9j">BMC Fam Pract</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">130</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lebeau J-P, Cadwallader J-S, Aubin-Auger I, Mercier A, Pasquet T, Rusch E, et al. The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review. BMC Fam Pract. 2014;15:130. [PubMed: 24989986]</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_UZF6wJ2">Clinical Inertia</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Branch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Doyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>El-Kebbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Gallina</surname></persName>
		</author>
		<idno type="PMID">11694107</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8WDKJXD">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="825" to="834" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical Inertia. Ann Intern Med. 2001;135:825-34. [PubMed: 11694107]</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_zRthsjm">Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Bellows</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ruiz-Negrón</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bibbins-Domingo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Pletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Moran</surname></persName>
		</author>
		<idno type="PMID">31163981</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8E68V6s">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">5624</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bellows BK, Ruiz-Negrón N, Bibbins-Domingo K, King JB, Pletcher MJ, Moran AE, et al. Clinic- Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals. Circ Cardiovasc Qual Outcomes. 2019;12:e005624. [PubMed: 31163981]</note>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main" xml:id="_dFWTWwy">Clinical Inertia and Outpatient Medical Errors</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>O'connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Sperl-Hillen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Rush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Biltz</surname></persName>
		</author>
		<editor>Henriksen K, Battles JB, Marks ES, Lewin DI</editor>
		<imprint>
			<date type="published" when="2005">2005</date>
			<publisher>Agency for Healthcare Research and Quality</publisher>
			<biblScope unit="volume">2</biblScope>
			<pubPlace>Rockville, MD</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">O&apos;Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Biltz G. Clinical Inertia and Outpatient Medical Errors. Volume 2: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Rockville, MD: Agency for Healthcare Research and Quality; 2005.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_TMvwCZT">Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Jaffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sidney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Go</surname></persName>
		</author>
		<idno type="PMID">23989679</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FgEUJXZ">JAMA</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="699" to="705" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program. JAMA. 2013;310:699-705. [PubMed: 23989679]</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_jh5vvuM">Blood pressure control among US veterans: A large multiyear analysis of blood pressure data from the veterans administration health data repository</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Amdur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kolodner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mcmanus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Faselis</surname></persName>
		</author>
		<idno type="PMID">22515976</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kkRxas6">Circulation</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="2462" to="2468" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fletcher RD, Amdur RL, Kolodner R, McManus C, Jones R, Faselis C, et al. Blood pressure control among US veterans: A large multiyear analysis of blood pressure data from the veterans administration health data repository. Circulation. 2012;125:2462-8. [PubMed: 22515976]</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_XhTN5kb">Team-based care with pharmacists to improve blood pressure: A review of recent literature</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Kennelty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Polgreen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11906-018-0803-0</idno>
		<idno type="PMID">29349522</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aErHs5d">Curr Hypertens Rep</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kennelty KA, Polgreen LA, Carter BL. Team-based care with pharmacists to improve blood pressure: A review of recent literature. Curr Hypertens Rep. 2018;20:1. [PubMed: 29349522]</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_HjdhkxF">The Hypertension Team: The Role of the Pharmacist, Nurse and Teamwork in Hypertension Therapy</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Bosworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Green</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2tDU39t">J Clin Hypertens</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="51" to="65" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Carter BL, Bosworth HB, Green BB. The Hypertension Team: The Role of the Pharmacist, Nurse and Teamwork in Hypertension Therapy. J Clin Hypertens. 2012;14:51-65.</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_v3AnzQk">Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-analysis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Obst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Molina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>He</surname></persName>
		</author>
		<idno type="DOI">10.7326/m17-1805</idno>
		<idno type="PMID">29277852</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F74ag3N">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">168</biblScope>
			<biblScope unit="page" from="110" to="120" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>Systematic review and meta-analysis that describes the effectiveness of various strategies for improving hypertension management</note>
	<note type="raw_reference">Mills KT, Obst KM, Shen W, Molina S, Zhang H-J, He H, et al. Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-analysis. Ann Intern Med. 2018;168:110-20. [PubMed: 29277852] ** Systematic review and meta-analysis that describes the effectiveness of various strategies for improving hypertension management.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_TC5RfsY">The Role of the Clinical Pharmacist in the Care of Patients with Cardiovascular Disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Dunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Birtcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Beavers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Brouse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">I</forename><surname>Page</surname></persName>
		</author>
		<author>
			<persName><surname>Rl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_X4vCHnM">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="2129" to="2139" />
			<date type="published" when="2015">2015</date>
			<publisher>Elsevier</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Dunn SP, Birtcher KK, Beavers CJ, Baker WL, Brouse SD, Page II RL, et al. The Role of the Clinical Pharmacist in the Care of Patients with Cardiovascular Disease. J Am Coll Cardiol. Elsevier; 2015;66:2129-39.</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_hHE66hh">Cluster-Randomized Trial of a Physician/Pharmacist Collaborative Model to Improve Blood Pressure Control</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Coffey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ardery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Uribe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ecklund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>James</surname></persName>
		</author>
		<idno type="PMID">25805647</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WK24Yyw">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="235" to="243" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, et al. Cluster-Randomized Trial of a Physician/Pharmacist Collaborative Model to Improve Blood Pressure Control. Circ Cardiovasc Qual Outcomes. 2015;8:235-43. [PubMed: 25805647]</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_6JHpa2c">Effect of Home Blood Pressure Telemonitoring and Pharmacist Management On Blood Pressure Control: The HyperLink Cluster Randomized Trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Margolis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Asche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Bergdall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Dehmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Groen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kadrmas</surname></persName>
		</author>
		<idno type="PMID">23821088</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_a3h2QC3">JAMA</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="46" to="56" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of Home Blood Pressure Telemonitoring and Pharmacist Management On Blood Pressure Control: The HyperLink Cluster Randomized Trial. JAMA. 2013;310:46-56. [PubMed: 23821088]</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_emNUnfz">A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Victor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Blyler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Muhammad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Handler</surname></persName>
		</author>
		<idno type="PMID">29527973</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_V4DmKdZ">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">378</biblScope>
			<biblScope unit="page" from="1291" to="1301" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>Cluster-randomized trial of a pharmacist-driven blood pressure management service in black barbershops</note>
	<note type="raw_reference">Victor RG, Lynch K, Li N, Blyler C, Muhammad E, Handler J, et al. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med. 2018;378:1291-301. [PubMed: 29527973] ** Cluster-randomized trial of a pharmacist-driven blood pressure management service in black barbershops.</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_3mW2G9d">Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Margolis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Asche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Dehmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Bergdall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Sperl-Hillen</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2018.1617</idno>
		<idno type="PMID">30646139</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_83Qavqa">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">181617</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>-month outcomes related to pharmacist-driven telehealth blood pressure management service</note>
	<note type="raw_reference">Margolis KL, Asche SE, Dehmer SP, Bergdall AR, Green BB, Sperl-Hillen JM, et al. Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial. JAMA Netw Open. 2018;1:e181617. [PubMed: 30646139] * 24-month outcomes related to pharmacist-driven telehealth blood pressure management service.</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_NRCyp86">Sustainability of Blood Pressure Reduction in Black Barbershops</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Victor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Blyler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">B</forename><surname>Moy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rashid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tsK8xaQ">Circulation</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="10" to="19" />
			<date type="published" when="2019">2019</date>
			<publisher>Lippincott Williams and Wilkins</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Victor RG, Blyler CA, Li N, Lynch K, Moy NB, Rashid M, et al. Sustainability of Blood Pressure Reduction in Black Barbershops. Circulation. Lippincott Williams and Wilkins; 2019;139:10-9.</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_AaP7Ykw">Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Asche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Dehmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Bergdall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Maciosek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename></persName>
		</author>
		<idno type="PMID">27720142</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pUgPBuM">J Am Soc Hypertens</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="873" to="880" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Asche SE, O&apos;Connor PJ, Dehmer SP, Green BB, Bergdall AR, Maciosek MV, et al. Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management. J Am Soc Hypertens. 2016;10:873-80. [PubMed: 27720142]</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_XVVwUtx">Key components of success in a randomized trial of blood pressure telemonitoring with medication therapy management pharmacists</title>
		<author>
			<persName><forename type="first">M</forename><surname>Beran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Asche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Bergdall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Crabtree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Groen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6ZrcBqb">J Am Pharm Assoc</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="614" to="621" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Beran M, Asche SE, Bergdall AR, Crabtree B, Green BB, Groen SE, et al. Key components of success in a randomized trial of blood pressure telemonitoring with medication therapy management pharmacists. J Am Pharm Assoc. 2018;58:614-21.</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_wvajZWu">Expanding the Role of Nurses to Improve Hypertension Care and Control Globally</title>
		<author>
			<persName><forename type="first">Dennison</forename><surname>Himmelfarb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Commodore-Mensah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.aogh.2016.02.003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CDHPfXu">Ann Glob Heal</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="243" to="253" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dennison Himmelfarb CR, Commodore-Mensah Y, Hill MN. Expanding the Role of Nurses to Improve Hypertension Care and Control Globally. Ann Glob Heal. 2016;82:243-53.</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_wpnzJbT">Effects of nursemanaged protocols in the outpatient management of adults with chronic conditions: A systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mcduffie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Hendrix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Edie</forename><forename type="middle">A</forename><surname>Lindsey-Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Nagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="PMID">25023250</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Bfwus7b">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="113" to="121" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shaw RJ, McDuffie JR, Hendrix CC, Edie A, Lindsey-Davis L, Nagi A, et al. Effects of nurse- managed protocols in the outpatient management of adults with chronic conditions: A systematic review and meta-analysis. Ann Intern Med. 2014;161:113-21. [PubMed: 25023250]</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_qttJYng">Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lfp</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Campbell</surname></persName>
		</author>
		<idno type="PMID">20732968</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TZXZrgV">BMJ</title>
		<imprint>
			<biblScope unit="volume">341</biblScope>
			<biblScope unit="page">3995</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Clark CE, Smith LFP, Taylor RS, Campbell JL. Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis. BMJ. 2010;341:c3995. [PubMed: 20732968]</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_DTN49VH">Nurse-led interventions used to improve control of high blood pressure in people with diabetes: A systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lfp</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Campbell</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1464-5491.2010.03204.x</idno>
		<idno type="PMID">21309833</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pumef9x">Diabet Med</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="250" to="261" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Clark CE, Smith LFP, Taylor RS, Campbell JL. Nurse-led interventions used to improve control of high blood pressure in people with diabetes: A systematic review and meta-analysis. Diabet Med. 2011;28:250-61. [PubMed: 21309833]</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_Tyddevt">A Systematic Review of Economic Evidence on Community Hypertension Interventions</title>
		<author>
			<persName><forename type="first">D</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Joo</surname></persName>
		</author>
		<idno type="PMID">29153113</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XmAGMPP">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="121" to="130" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>** This systematic review describes the cost-effectiveness evidence on various team-based care strategies for hypertension management in the United States and Internationally</note>
	<note type="raw_reference">Zhang D, Wang G, Joo H. A Systematic Review of Economic Evidence on Community Hypertension Interventions. Am J Prev Med. 2017;53:S121-30. [PubMed: 29153113] ** This systematic review describes the cost-effectiveness evidence on various team-based care strategies for hypertension management in the United States and Internationally.</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main" xml:id="_ey2qMQU">Economics of Teambased Care in Controlling Blood Pressure: A Community Guide Systematic Review</title>
		<author>
			<persName><forename type="first">V</forename><surname>Jacob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Chattopadhyay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Thota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Proia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Njie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Hopkins</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2015.04.003</idno>
		<idno type="PMID">26477804</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FPBKrrS">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="772" to="783" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jacob V, Chattopadhyay SK, Thota AB, Proia KK, Njie G, Hopkins DP, et al. Economics of Team- based Care in Controlling Blood Pressure: A Community Guide Systematic Review. Am J Prev Med. 2015;49:772-83. [PubMed: 26477804]</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main" xml:id="_hGrZ9yW">A Cluster-Randomized Trial to Evaluate Physician/Pharmacist Collaboration to Improve Blood Pressure Control</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Bergus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Dawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Farris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Doucette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Chrischilles</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YGNCUb3">J Clin Hypertens</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="260" to="271" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, et al. A Cluster- Randomized Trial to Evaluate Physician/Pharmacist Collaboration to Improve Blood Pressure Control. J Clin Hypertens. 2008;10:260-71.</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main" xml:id="_ZxY7Bea">Physician/ Pharmacist Collaboration to Improve Blood Pressure Control</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ardery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Dawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Bergus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Doucette</surname></persName>
		</author>
		<idno type="PMID">19933962</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DJC3qyg">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="1996" to="2002" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, et al. Physician/ Pharmacist Collaboration to Improve Blood Pressure Control. Arch Intern Med. 2009;169:1996- 2002. [PubMed: 19933962]</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main" xml:id="_xJP8qWN">Cost Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Polgreen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Ardery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Coffey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Chrischilles</surname></persName>
		</author>
		<idno type="PMID">26527048</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NW4kD34">Hypertension</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="1145" to="1151" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Polgreen LA, Han J, Carter BL, Ardery GP, Coffey CS, Chrischilles EA, et al. Cost Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control. Hypertension. 2015;66:1145-51. [PubMed: 26527048]</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main" xml:id="_9jcnY7z">Incremental Costs associated with Physician and Pharmacist Collaboration to Improve Blood Pressure Control</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kulchaitanaroaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ardery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<idno type="PMID">23307525</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Eb8mtWx">Pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="772" to="780" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kulchaitanaroaj P, Brooks JM, Ardery G, Newman D, Carter BL. Incremental Costs associated with Physician and Pharmacist Collaboration to Improve Blood Pressure Control. Pharmacotherapy. 2012;32:772-80. [PubMed: 23307525]</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main" xml:id="_kfVXMGZ">Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Dehmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Maciosek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Trower</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Asche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Bergdall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Nyboer</surname></persName>
		</author>
		<idno type="PMID">30320302</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JBZSWAa">J Am Coll Clin Pharm</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="21" to="30" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dehmer SP, Maciosek MV, Trower NK, Asche SE, Bergdall AR, Nyboer RA, et al. Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial. J Am Coll Clin Pharm. 2018;1:21-30. [PubMed: 30320302]</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main" xml:id="_dHFDaN9">Modeling the Health and Budgetary Impacts of a Team-based Hypertension Care Intervention That Includes Pharmacists</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Overwyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Dehmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Maciosek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><surname>Baker-Goering</surname></persName>
		</author>
		<author>
			<persName><surname>Mm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GXd4xdp">Med Care</title>
		<imprint>
			<biblScope unit="volume">00</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note>Economic analysis evaluating cost thresholds for pharmacist-delivered hypertension service to be budget-neutral in Medicare populations</note>
	<note type="raw_reference">Overwyk KJ, Dehmer SP, Roy K, Maciosek MV, Hong Y, Baker-goering MM, et al. Modeling the Health and Budgetary Impacts of a Team-based Hypertension Care Intervention That Includes Pharmacists. Med Care. 2019;00:1-8.** Economic analysis evaluating cost thresholds for pharmacist-delivered hypertension service to be budget-neutral in Medicare populations.</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main" xml:id="_NmGh85G">Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kulchaitanaroaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chaiyakunapruk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Goedken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Chrischilles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<idno type="DOI">10.1097/hjh.0000000000001126</idno>
		<idno type="PMID">27684354</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jeewwtc">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="178" to="187" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kulchaitanaroaj P, Brooks JM, Chaiyakunapruk N, Goedken AM, Chrischilles EA, Carter BL. Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care. J Hypertens. 2017;35:178-87. [PubMed: 27684354]</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main" xml:id="_5gkXmXF">Cost-Effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Lier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Majumdar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Tsuyuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">Z</forename><surname>Lewanczuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Spooner</surname></persName>
		</author>
		<idno type="DOI">10.1111/dme.12692</idno>
		<idno type="PMID">25594919</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rrC6UhJ">Diabet Med</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="899" to="906" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Simpson SH, Lier DA, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, et al. Cost- Effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial. Diabet Med. 2015;32:899-906. [PubMed: 25594919]</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main" xml:id="_YuxebbF">Cost-effectiveness of pharmacist care for managing hypertension in Canada</title>
		<author>
			<persName><forename type="first">C</forename><surname>Marra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Santschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Tsuyuki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3E8Qy4g">Can Pharm J</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="184" to="197" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Marra C, Johnston K, Santschi V, Tsuyuki RT. Cost-effectiveness of pharmacist care for managing hypertension in Canada. Can Pharm J. 2017;150:184-97.</note>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main" xml:id="_tMm53mj">Effectiveness of a Patient-Tailored, Pharmacist-Led Intervention Program to Enhance Adherence to Antihypertensive Medication: The CATI Study</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Van Der Laan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pjm</forename><surname>Elders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cclm</forename><surname>Boons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nijpels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Van Dijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Hugtenburg</surname></persName>
		</author>
		<idno type="PMID">29387012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gMv8gBq">Front Pharmacol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="1" to="13" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van der Laan DM, Elders PJM, Boons CCLM, Nijpels G, van Dijk L, Hugtenburg JG. Effectiveness of a Patient-Tailored, Pharmacist-Led Intervention Program to Enhance Adherence to Antihypertensive Medication: The CATI Study. Front Pharmacol. 2018;9:1-13. [PubMed: 29387012]</note>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main" xml:id="_mpQEU2b">The Cost-Effectiveness of an Intervention Program to Enhance Adherence to Antihypertensive Medication in Comparison With Usual Care in Community Pharmacies</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Bosmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Van Der Laan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pjm</forename><surname>Elders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cclm</forename><surname>Boons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nijpels</surname></persName>
		</author>
		<idno type="PMID">30899223</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8DgzPvW">Front Pharmacol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">210</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bosmans JE, van der Laan DM, Yang Y, Elders PJM, Boons CCLM, Nijpels G, et al. The Cost- Effectiveness of an Intervention Program to Enhance Adherence to Antihypertensive Medication in Comparison With Usual Care in Community Pharmacies. Front Pharmacol. 2019;10:210. [PubMed: 30899223]</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main" xml:id="_spuDdTS">Nurse practitioners as an underutilized resource for health reform: Evidence-based demonstrations of cost-effectiveness</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Bauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_w8PDkm7">Am Acad Nurse Pract</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="228" to="231" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bauer JC. Nurse practitioners as an underutilized resource for health reform: Evidence-based demonstrations of cost-effectiveness. Am Acad Nurse Pract. 2010;22:228-31.</note>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main" xml:id="_CVk9Ccc">Patient education and provider decision support to control blood pressure in primary care: A cluster randomized trial</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Bosworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dudley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Orr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Datta</surname></persName>
		</author>
		<idno type="PMID">19249414</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_prgXMzh">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="450" to="456" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bosworth HB, Olsen MK, Dudley T, Orr M, Goldstein MK, Datta SK, et al. Patient education and provider decision support to control blood pressure in primary care: A cluster randomized trial. Am Heart J. 2009;157:450-6. [PubMed: 19249414]</note>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main" xml:id="_THEXzDc">Economic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patients</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Datta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Z</forename><surname>Oddone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Orr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mccant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gentry</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2010.05.024</idno>
		<idno type="PMID">20691830</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UsUkwda">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="257" to="263" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Datta SK, Oddone EZ, Olsen MK, Orr M, McCant F, Gentry P, et al. Economic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patients. Am Heart J. 2010;160:257-63. [PubMed: 20691830]</note>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main" xml:id="_AhSWEMy">Cost-effectiveness of Nurse Practitioner/Community Health Worker Care to Reduce Cardiovascular Health Disparities</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dennison</forename><surname>Himmelfarb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Szanton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Hopkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Frick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename></persName>
		</author>
		<idno type="PMID">23635809</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XsahfvF">J Cardiovasc Nurs</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="308" to="314" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Allen JK, Dennison Himmelfarb CR, Szanton SL, Hopkins J, Frick KD. Cost-effectiveness of Nurse Practitioner/Community Health Worker Care to Reduce Cardiovascular Health Disparities. J Cardiovasc Nurs. 2014;29:308-14. [PubMed: 23635809]</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main" xml:id="_JTartXZ">Trends in State Regulation of Nurse Practitioners and Physician Assistants, 2001 to 2010</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Gadbois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tyler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Intrator</surname></persName>
		</author>
		<idno type="DOI">10.1177/1077558714563763</idno>
		<idno type="PMID">25542195</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VVcMwBz">Med Care Res Rev</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="200" to="219" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gadbois EA, Miller EA, Tyler D, Intrator O. Trends in State Regulation of Nurse Practitioners and Physician Assistants, 2001 to 2010. Med Care Res Rev. 2015;72:200-19. [PubMed: 25542195]</note>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main" xml:id="_hFqqxj3">Pharmacist-provided services: Barriers to demonstrating value</title>
		<author>
			<persName><forename type="first">E</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Holmes</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.japh.2018.11.007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ezxbRA2">J Am Pharm Assoc</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="117" to="120" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nguyen E, Holmes JT. Pharmacist-provided services: Barriers to demonstrating value. J Am Pharm Assoc. 2019;59:117-20.</note>
</biblStruct>

<biblStruct xml:id="b82">
	<monogr>
		<idno type="DOI">10.1331/japha.2015.14176</idno>
		<title level="m" xml:id="_rsD7Wyt">The pursuit of provider status</title>
		<imprint>
			<publisher>American Pharmacists Association</publisher>
		</imprint>
	</monogr>
	<note>Internet</note>
	<note type="raw_reference">American Pharmacists Association. The pursuit of provider status [Internet].</note>
</biblStruct>

<biblStruct xml:id="b83">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Washington</surname></persName>
		</author>
		<ptr target="www.ssa.gov/OP_Home/" />
		<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Washington, D.C.; 2013 Available from: www.ssa.gov/OP_Home/</note>
</biblStruct>

<biblStruct xml:id="b84">
	<monogr>
		<title level="m" type="main" xml:id="_7mKq7Ah">Update The Complexities of Physician Supply and Demand: Projections from 2015 to 2030</title>
		<idno type="DOI">10.1037/e514442018-001</idno>
		<imprint>
			<date type="published" when="2017">2017</date>
			<publisher>IHS Markit</publisher>
		</imprint>
	</monogr>
	<note>Internet</note>
	<note type="raw_reference">IHS Markit. 2017 Update The Complexities of Physician Supply and Demand: Projections from 2015 to 2030 [Internet].</note>
</biblStruct>

<biblStruct xml:id="b85">
	<monogr>
		<title level="m" type="main" xml:id="_7V7X4Av">Available from</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Washington</surname></persName>
		</author>
		<ptr target="https://aamc-black.global.ssl.fastly.net/production/media/filer_public/a5/c3/a5c3d565-14ec-48fb-974b-99fafaeecb00/aamc_projections_update_2017.pdf" />
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Washington, D.C.; 2017. Available from: https://aamc- black.global.ssl.fastly.net/production/media/filer_public/a5/c3/ a5c3d565-14ec-48fb-974b-99fafaeecb00/aamc_projections_update_2017.pdf</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main" xml:id="_DBmRhqx">Primary Health Care as a Foundation for Strengthening Health Systems in Low-and Middle-Income Countries</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bitton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Ratcliffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Veillard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Kress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Barkley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kimball</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11606-016-3898-5</idno>
		<idno type="PMID">27943038</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vv6wJhx">J Gen Intern Med</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="566" to="571" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bitton A, Ratcliffe HL, Veillard JH, Kress DH, Barkley S, Kimball M, et al. Primary Health Care as a Foundation for Strengthening Health Systems in Low-and Middle-Income Countries. J Gen Intern Med. 2016;32:566-71. [PubMed: 27943038]</note>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main" xml:id="_gVCD5KC">Druetz T Integrated primary health care in low-and middle-income countries: a double challenge</title>
		<idno type="DOI">10.1186/s12910-018-0288-z</idno>
		<idno type="PMID">29945623</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4mHtjqg">BMC Med Ethics</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">48</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Druetz T Integrated primary health care in low-and middle-income countries: a double challenge. BMC Med Ethics. 2018;19:48. [PubMed: 29945623]</note>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main" xml:id="_RvtD22J">Primary Care Research Priorities in Low-and Middle-Income Countries</title>
		<author>
			<persName><forename type="first">F</forename><surname>Goodyear-Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bazemore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Coffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fortier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Howe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kidd</surname></persName>
		</author>
		<idno type="DOI">10.1370/afm.2329</idno>
		<idno type="PMID">30670392</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4jyheRH">Ann Fam Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="31" to="35" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goodyear-Smith F, Bazemore A, Coffman M, Fortier R, Howe A, Kidd M, et al. Primary Care Research Priorities in Low-and Middle-Income Countries. Ann Fam Med. 2019;17:31-5. [PubMed: 30670392]</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main" xml:id="_Dsg7yRa">Models of care for chronic conditions in low/ middle-income countries: a &quot;best fit&quot; framework synthesis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Lall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Devadasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Horstman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Criel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Wv6b64v">BMJ Glob Heal</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e001077</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lall D, Engel N, Devadasan N, Horstman K, Criel B. Models of care for chronic conditions in low/ middle-income countries: a &quot;best fit&quot; framework synthesis. BMJ Glob Heal. 2018;3:e001077.</note>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main" xml:id="_bv8QaDe">Efficacy of selfmonitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mcmanus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Franssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nickless</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hodgkinson</surname></persName>
		</author>
		<idno type="PMID">29499873</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KwGEfDs">Lancet</title>
		<imprint>
			<biblScope unit="volume">391</biblScope>
			<biblScope unit="page" from="949" to="959" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self- monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391:949-59. [PubMed: 29499873]</note>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main" xml:id="_dANNMPG">Cost-Effectiveness of telemonitoring and self-monitoring of blood pressure for antihypertensive titration in primary care (TASMINH4)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Monahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jowett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nickless</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Franssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Greenfield</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.118.12415</idno>
		<idno type="PMID">31067190</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SvyJQ8e">Hypertension</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="1231" to="1239" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Monahan M, Jowett S, Nickless A, Franssen M, Grant S, Greenfield S, et al. Cost-Effectiveness of telemonitoring and self-monitoring of blood pressure for antihypertensive titration in primary care (TASMINH4). Hypertension. 2019;73:1231-9. [PubMed: 31067190]</note>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main" xml:id="_9XNXTUD">Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Tucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Sheppard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Bosworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Bray</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pmed.1002389</idno>
		<idno type="PMID">28926573</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rkn7U7F">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">1002389</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis. PLoS Med. 2017;14:e1002389. [PubMed: 28926573]</note>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main" xml:id="_27h8ppy">Nonadherence to antihypertensive drugs: A systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Abegaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shehab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Gebreyohannes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Bhagavathula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Elnour</surname></persName>
		</author>
		<idno type="DOI">10.1097/md.0000000000005641</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2T8XYN7">Medicine</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page">5641</biblScope>
			<date type="published" when="2017">2017</date>
			<publisher>Wolters Kluwer Health</publisher>
			<pubPlace>Baltimore)</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). Wolters Kluwer Health; 2017;96:e5641.</note>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main" xml:id="_W3n83xW">Adherence in hypertension: a review of prevalence, risk factors, impact, and management</title>
		<author>
			<persName><forename type="first">M</forename><surname>Burnier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Egan</surname></persName>
		</author>
		<idno type="DOI">10.1161/circresaha.118.313220</idno>
		<idno type="PMID">30920917</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_S5XPwZc">Circ Res</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="1124" to="1140" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Burnier M, Egan BM. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circ Res. 2019;124:1124-40. [PubMed: 30920917]</note>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main" xml:id="_4uMUXac">Adherence to Healthy Lifestyle Habits in US Adults, 1988-2006</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Iii</forename><surname>Mainous</surname></persName>
		</author>
		<author>
			<persName><surname>Ag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carnemolla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Everett</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amjmed.2008.11.013</idno>
		<idno type="PMID">19486715</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wRqKc5M">Am J Med</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="528" to="534" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">King DE, Mainous III AG, Carnemolla M, Everett CJ. Adherence to Healthy Lifestyle Habits in US Adults, 1988-2006. Am J Med. 2009;122:528-34. [PubMed: 19486715]</note>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main" xml:id="_qURPBau">Partnerships to Improve Shared Decision Making for Patients with Hypertension -Health Equity Implications</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Langford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Applegate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Ogedegbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Braithwaite</surname></persName>
		</author>
		<idno type="DOI">10.18865//ed.29.s1.97</idno>
		<idno type="PMID">30906156</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_C3Kjp53">Ethn Dis</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="97" to="102" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note>This paper, in conjunction with Johnson et al, describes the importance of implementing shared decision making to maximize hypertension care and reduce health disparities</note>
	<note type="raw_reference">Langford AT, Williams SK, Applegate M, Ogedegbe O, Braithwaite RS. Partnerships to Improve Shared Decision Making for Patients with Hypertension -Health Equity Implications. Ethn Dis. 2019;29:97-102. [PubMed: 30906156] * This paper, in conjunction with Johnson et al, describes the importance of implementing shared decision making to maximize hypertension care and reduce health disparities.</note>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main" xml:id="_6rrDJWN">Interventions to support shared decision making for hypertension: A systematic review of controlled studies</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Huntley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Perkins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DP4QE3g">Heal Expect</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1191" to="1207" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>This systematic review describes the current literature on strategies to improve shared decision making with patients in hypertension care</note>
	<note type="raw_reference">Johnson RA, Huntley A, Hughes RA, Cramer H, Turner KM, Perkins B, et al. Interventions to support shared decision making for hypertension: A systematic review of controlled studies. Heal Expect. 2018;21:1191-207.* This systematic review describes the current literature on strategies to improve shared decision making with patients in hypertension care.</note>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main" xml:id="_X3BxjVm">Using lean thinking to improve hypertension in a community health centre: a quality improvement report</title>
		<author>
			<persName><forename type="first">P</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Oakley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Eng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Freydin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rose</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YQMrrBF">BMJ Open Qual</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e000373</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note>This quality improvement paper describes the use of LEAN principles in the development of a hypertension care pathway using team-based care in an underserved setting</note>
	<note type="raw_reference">Lee P, Pham L, Oakley S, Eng K, Freydin E, Rose T, et al. Using lean thinking to improve hypertension in a community health centre: a quality improvement report. BMJ Open Qual. 2019;8:e000373.* This quality improvement paper describes the use of LEAN principles in the development of a hypertension care pathway using team-based care in an underserved setting.</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main" xml:id="_pNSMbp9">Cost Effectiveness of Intensive Blood-Pressure Control [abstract LBPS 03-01</title>
		<author>
			<persName><forename type="first">H-Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Jun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-W</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.hjh.0000501435.19786.c7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FKFWCQW">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page">e524</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee H-Y, Jun SY, Choi J-W, Kim TY. Cost Effectiveness of Intensive Blood-Pressure Control [abstract LBPS 03-01]. J Hypertens. 2016;34:e524.</note>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main" xml:id="_mE4uWvv">The Potency of Team-based Care Interventions for Hypertension</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Daly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>James</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinternmed.2009.316</idno>
		<idno type="PMID">19858431</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FZTVYSe">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="1748" to="1755" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Carter BL, Rogers M, Daly J, Zheng S, James PA. The Potency of Team-based Care Interventions for Hypertension. Arch Intern Med. 2009;169:1748-55. [PubMed: 19858431] 100.</note>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main" xml:id="_cwfEKbT">Community Outreach and Cardiovascular Health (COACH) Trial: A Randomized, Controlled Trial of Nurse Practitioner/Community Health Worker Cardiovascular Disease Risk Reduction in Urban Community Health Centers</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Dennison-Himmelfarb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Szanton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Levine</surname></persName>
		</author>
		<idno type="DOI">10.1161/circoutcomes.111.961573</idno>
		<idno type="PMID">21953407</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HnRQG22">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="595" to="602" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Allen JK, Dennison-Himmelfarb CR, Szanton SL, Bone L, Hill MN, Levine DM, et al. Community Outreach and Cardiovascular Health (COACH) Trial: A Randomized, Controlled Trial of Nurse Practitioner/Community Health Worker Cardiovascular Disease Risk Reduction in Urban Community Health Centers. Circ Cardiovasc Qual Outcomes. 2011;4:595-602. [PubMed: 21953407] 101</note>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main" xml:id="_hue76ez">Economic evaluation of telephone self-management interventions for blood pressure control</title>
		<author>
			<persName><forename type="first">V</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Bosworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Z</forename><surname>Oddone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mccant</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2012.03.016</idno>
		<idno type="PMID">22709750</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HNFD5JW">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="980" to="986" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang V, Smith VA, Bosworth HB, Oddone EZ, Olsen MK, McCant F, et al. Economic evaluation of telephone self-management interventions for blood pressure control. Am Heart J. 2012;163:980-6. [PubMed: 22709750] 102.</note>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main" xml:id="_YHU5dg9">Home Blood Pressure Management and Improved Blood Pressure Control: Results from a Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Bosworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Powers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mccant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Grubber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinternmed.2011.276</idno>
		<idno type="PMID">21747013</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7npG5gn">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page" from="1173" to="1180" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bosworth HB, Powers BJ, Olsen MK, McCant F, Grubber J, Smith V, et al. Home Blood Pressure Management and Improved Blood Pressure Control: Results from a Randomized Controlled Trial. Arch Intern Med. 2011;171:1173-80. [PubMed: 21747013] 103</note>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main" xml:id="_GFMEZmY">Cost-effectiveness of a peer and practice staff support intervention</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Hollenbeak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Weiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
		<idno type="PMID">24884753</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_x6r39eV">Am J Manag Care</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="253" to="260" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hollenbeak CS, Weiner MG, Turner BJ. Cost-effectiveness of a peer and practice staff support intervention. Am J Manag Care. 2014;20:253-60. [PubMed: 24884753]</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
